4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001577014-26-000010
Director sold 267,760 shares at an average $21.09 ($5,646,497)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rhodes Jason P Director | 2026-06-23 | Sale 10b5-1 | −77,855 | $21.13 | $1,645,076 | 4,805,639 | I |
| Rhodes Jason P Director | 2026-06-23 | Sale 10b5-1 | −39,131 | $21.13 | $826,838 | 1,510,157 | I |
| Rhodes Jason P Director | 2026-06-23 | Sale 10b5-1 | −30,774 | $21.13 | $650,255 | 1,106,036 | I |
| Rhodes Jason P Director | 2026-06-24 | Sale 10b5-1 | −50,530 | $21.02 | $1,062,141 | 4,755,109 | I |
| Rhodes Jason P Director | 2026-06-24 | Sale 10b5-1 | −25,397 | $21.02 | $533,845 | 1,484,760 | I |
| Rhodes Jason P Director | 2026-06-24 | Sale 10b5-1 | −19,973 | $21.02 | $419,832 | 1,086,063 | I |
| Rhodes Jason P Director | 2026-06-25 | Sale 10b5-1 | −12,699 | $21.10 | $267,949 | 4,742,410 | I |
| Rhodes Jason P Director | 2026-06-25 | Sale 10b5-1 | −6,382 | $21.10 | $134,660 | 1,478,378 | I |
| Rhodes Jason P Director | 2026-06-25 | Sale 10b5-1 | −5,019 | $21.10 | $105,901 | 1,081,044 | I |
| Open-market sales · 267,760 sh · avg $21.09 · $5,646,497 | |||||||
Loading xslF345X06/form4-06262026_120619.xml…